[Controlled clinical trial of 5(4)-amino-4(5)-imidazole carboxyamide ureidosuccinate, a new hepatic therapeutic agent stimulating liver regeneration and protein anabolism].
D000328:Adult; D000368:Aged; D000620:Aminoimidazole Carboxamide / Q000627:therapeutic use*; D001798:Blood Proteins / Q000032:analysis; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008107:Liver Diseases / Q000188:drug therapy*; D008111:Liver Function Tests; D008115:Liver Regeneration / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D011506:Proteins / Q000378:metabolism*
D001798:Blood Proteins; D007093:Imidazoles; D011506:Proteins; D000620:Aminoimidazole Carboxamide
Esperienza clinica controllata con ureidosuccinato di 5(4)-amino-4(5)-imidazolcarbossiamide, nuovo epatoterapico stimolante la rigenerazione epatica e l'anabolismo proteico.